ACST - Acasti Pharma updates on Trilogy 1 and 2 trials; shares up 4% premarket September, 30 2019 08:54 AM Acasti Pharma Inc. Acasti Pharma (NASDAQ:ACST) reports additional milestones reached and provides a business update on its clinical trials.More news on: Acasti Pharma Inc., Healthcare stocks news, Stocks on the move, Read more ...